SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-14-000330
Filing Date
2014-08-12
Accepted
2014-08-12 14:28:29
Documents
1
Group Members
ANTHONY A. FLORENCE JR.DAVID M. MOTTFOREST BASKETTHARRY R. WELLERKRISHNA S. KOLLURIMICHAEL JAMES BARRETTNEA 14 GP LTDNEA PARTNERS 14 L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANRYAN D. DRANTSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 LOXO ONCOLOGY loxo-sch13d_17686.htm SC 13D 471020
  Complete submission text file 0001072613-14-000330.txt   472988
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 14, L.P. (Filed by) CIK: 0001544328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-658-4749
Loxo Oncology, Inc. (Subject) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88267 | Film No.: 141033531
SIC: 2834 Pharmaceutical Preparations